Preimplantation Genetic Testing Market is Estimated to grow at a CAGR of 12.5% during the forecast period
Preimplantation genetic testing Market was
estimated to be worth USD 0.8 billion in 2023, and during the 2024–2034
forecast period, it is expected to grow at a compound annual growth rate (CAGR)
of 12.5% to reach USD 2.2 billion. By choosing embryos devoid of genetic
defects, preimplantation genetic testing dramatically raises the likelihood of
a fruitful pregnancy and the birth of a healthy kid. The market is increasing
and sustainable since it is in line with the healthcare industry.
Preimplantation genetic testing (PGT) is a medical method that
identifies defective embryos early on in the prenatal genetic diagnosis
process, allowing genetically normal embryos to be transferred. Procedures
involving assisted reproductive technology (ART) now include this technology as
a necessary component. The process entails examining embryos for distinct
genetic disorders or chromosomal irregularities to guarantee that solely sound
embryos are inserted into the uterus. For older women having IVF, couples at
risk of passing on genetic diseases, and couples with a history of recurrent
miscarriages, these procedures are essential.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/preimplantation-genetic-testing-market
GROWTH DRIVERS
One of the main factors propelling the market is the rise
in the prevalence of chromosomal abnormalities and genetic disorders. In
developed nations, congenital anomalies and genetic illnesses may account for
as much as 50% of childhood fatalities. Additionally, up to 30% of pediatric
hospital hospitalizations may be related to these illnesses. An estimated 240
000 infants worldwide pass away from congenital diseases within 28 days of
birth each year. An additional 170,000 children between the ages of 1 month and
5 years die as a result of congenital diseases.
Additionally, the study discovered that infertility rates
are comparable in high-, middle-, and low-income nations. The increased
investment in healthcare, particularly in developing nations, has lowered the
cost of advanced reproductive technology. People will be able to afford and
utilize PGT services to a
greater extent as their disposable income increases and healthcare
infrastructure advances. The WHO and Becker report that the expense of
healthcare increased to a record high of 10.7% in 2023 from 7.4% in 2022.
Globally, the insurer-reported cost trend is expected to average 9.9% in 2024,
with some regions experiencing a more significant increase.
MARKET
SEGMENTATION:
· By
Product & Services- reagent and consumables, instruments, software and
services
· By
Procedure Type- Preimplantation Genetic Diagnosis & Preimplantation
Genetic Screening
· By
Technology- Next-Generation Sequencing, Fluorescence In-Situ Hybridization,
Polymerase Chain Reaction, Comparative Genomic Hybridization and
Single-Nucleotide Polymorphism
· By
Application- Structural Chromosomal Abnormalities (Translocations, Deletions,
Inversions, Duplication), Aneuploidy, Gender Identification, Single Gene
Disorders, X-Linked Disorders, HLA Typing
· By
Type of Cycle- Fresh Donor, Fresh Non- Donor, Frozen Donor, Frozen
Non-Donor
· By
End-User- Hospitals, Diagnostic Laboratories, Fertility Clinics
· By
Region- North America, Europe, Asia Pacific, The Middle East and
Africa, South America
Global Key
Players:
· Illumina,
Inc.
· Thermo
Fisher Scientific Inc.
· CooperSurgical,
Inc.
· Agilent
Technologies, Inc.
· Revvity
· Abbott
· Takara
Bio, Inc.
· Qiagen
· Vitrolife
· Oxford
Nanopore Technologies
· Bioarray
S.L.
· Other
Players
For
More Information about this Report @ https://www.xresearch.biz/shop/preimplantation-genetic-testing-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Comments
Post a Comment